Environmental Protection in the Manufacture, Use and Disposal of Our Medicines
Pfizer is committed to minimizing the potential environmental impact related to the production of antibiotics. In 2016, Pfizer and 12 industry partners released a comprehensive plan of action that outlined key commitments to reduce the rising incidence of Antimicrobial Resistance (AMR). In 2017, we put that plan into action and took a leading role in the AMR Industry Alliance by spearheading its manufacturing group (the Alliance Manufacturing Group).
As a member of the Alliance, Pfizer is developing solutions to address the potential impact of manufacturing discharges on AMR. We worked with the Alliance Manufacturing Group to establish science-driven, risk-based targets for discharge concentrations for antibiotics and we agree on a common Alliance Manufacturing Framework (the Framework) for managing antibiotic wastewater discharges. Pfizer is committed to implementing the Framework across our supply chain and working toward meeting the recently published discharge targets.
While Pfizer and other AMR Industry Alliance manufacturers work to deliver their respective commitments, success in addressing antibiotic manufacturing concerns will require good environmental management practices to be adopted across the entire industry antibiotic supply chain. We believe that widespread adoption of the Alliance Manufacturing Framework will be a key step in this direction. To this end Pfizer worked with the Pharmaceutical Supply Chain Initiative, to incorporate the requirements of the Framework into supplier auditing protocols.
Access our policy paper on our antibiotic stewardship.